Ignite Creation Date:
2024-05-06 @ 2:16 PM
Last Modification Date:
2024-10-26 @ 1:28 PM
Study NCT ID:
NCT04265534
Status:
TERMINATED
Last Update Posted:
2022-09-21
First Post:
2020-02-07
Brief Title:
KEAPSAKE A Study of Telaglenastat CB-839 With Standard-of-Care Chemoimmunotherapy in 1L KEAP1NRF2-Mutated Nonsquamous NSCLC
Sponsor:
Organization:
Calithera Biosciences Inc